Combination treatment with T4 and T3: Toward personalized replacement therapy in hypothyroidism?

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 7, 2012, Pages 2256-2271

  Biondi, Bernadette ^a   Wartofsky, Leonard ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LEVOTHYROXINE; LIOTHYRONINE; LOW DENSITY LIPOPROTEIN; SEX HORMONE BINDING GLOBULIN; THYROXINE; TRIACYLGLYCEROL;

ANXIETY DISORDER; ATTENTION DISTURBANCE; AUTOIMMUNE THYROIDITIS; BODY COMPOSITION; BODY WEIGHT; BONE TURNOVER; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; COGNITION; COGNITIVE DEFECT; CONCENTRATION LOSS; DEIODINASE 2 GENE; DEPRESSION; DRUG MEGADOSE; ENERGY EXPENDITURE; GENE; GENETIC POLYMORPHISM; HEART RATE; HORMONE SUBSTITUTION; HUMAN; HYPOPHYSIS THYROID SYSTEM; HYPOTHYROIDISM; LANGUAGE DISABILITY; LOW DRUG DOSE; MEMORY DISORDER; MONOTHERAPY; MOOD; MOOD DISORDER; MOTOR DYSFUNCTION; NONHUMAN; PATIENT PREFERENCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK REDUCTION; SIDE EFFECT; SYMPTOM; THYROID HORMONE METABOLISM; THYROIDECTOMY; WEIGHT REDUCTION; DRUG COMBINATION; EVALUATION; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; PERSONALIZED MEDICINE; PHYSIOLOGY; THYROID GLAND;

DRUG COMBINATIONS; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOTHYROIDISM; INDIVIDUALIZED MEDICINE; THYROID GLAND; THYROXINE; TRIIODOTHYRONINE;

EID: 84863583977     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-3399     Document Type: Review

References (95)

1. Roberts CG, Ladenson PW 2004 Hypothyroidism. Lancet 363:793-803 (Pubitemid 38315171)
2. Cooper DS, Biondi B 2012 Subclinical thyroid disease. Lancet 379: 1142-1154
3. Biondi B, Cooper DS 2008 The clinical significance of subclinical thyroid dysfunction. Endocr Rev 29:76-131 (Pubitemid 351252748)
4. Murray GR 1891 Note on the treatment of myxoedema by hypodermic injections of an extract of the thyroid gland of a sheep. BMJ 2:796-797
5. Lindholm J, Laurberg P 2011 Hypothyroidism and thyroid substitution: historical aspects. J Thyroid Res 2011:809341
6. Braverman LE, Ingbar SH, Sterling K 1970 Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects. J Clin Invest 49:855-864
7. Baskin HJ, Cobin RH, Duick DS, Gharib H, Guttler RB, Kaplan MM, Segal RL 2002 American Association of Clinical Endocrinologists American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 8:457-469
8. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman C, Cooper RS, Weissman NJ 2004 Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 291:228-238 (Pubitemid 38082818)
9. Singer PA, Cooper DS, Levy EG, Ladenson PW, Braverman LE, Daniels G, Greenspan FS, McDougall IR, Nikolai TF 1995 Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association. JAMA 273:808-812
10. Abalovich M, Amino N, Barbour LA, Cobin RH, De Groot LJ, Glinoer D, Mandel SJ, Stagnaro-Green A 2007 Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 92:S1-S47 (Pubitemid 47236338)
11. Wartofsky L 2005 Levothyroxine therapy for hypothyroidism: should we abandon conservative dosage titration? Arch Intern Med 165:1683-1684 (Pubitemid 41138953)
12. Pilo A, Iervasi G, Vitek F, Ferdeghini M, Cazzuola F, Bianchi R 1990 Thyroidal and peripheral production of 3,5,3′-triiodothyronine in humans by multicompartmental analysis. Am J Physiol 258:E715-E726 (Pubitemid 20142356)
13. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR 2002 Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23:38-89 (Pubitemid 34185306)
14. Celi FS, Zemskova M, Linderman JD, Babar NI, Skarulis MC, Csako G, Wesley R, Costello R, Penzak SR, Pucino F 2010 The pharmacodynamic equivalence of levothyroxine and liothyronine: a randomized, double blind, cross-over study in thyroidectomized patients. Clin Endocrinol (Oxf) 72:709-715
15. Carlson HE, Hershman JM 1975 The hypothalamic-pituitary-thyroid axis. Med Clin North Am 59:1045-1053
16. Andersen S, Pedersen KM, Bruun NH, Laurberg P 2002 Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab 87:1068-1072 (Pubitemid 36121067)
17. Surks MI, Boucai L 2010 Age- and race-based serum thyrotropin reference limits. J Clin Endocrinol Metab 95:496-502
18. Liewendahl K, Helenius T, Lamberg BA, Mähönen H, Wägar G 1987 Free thyroxine, free triiodothyronine, and thyrotropin concentrations in hypothyroid and thyroid carcinoma patients receiving thyroxine therapy. Acta Endocrinol (Copenh) 116:418-424 (Pubitemid 17154210)
19. Woeber KA 2002 Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations. J Endocrinol Invest 25: 106-109 (Pubitemid 34232608)
20. Jonklaas J, Davidson B, Bhagat S, Soldin SJ 2008 Triiodothyronine levels in athyreotic individuals during levothyroxine therapy. JAMA 299:769-777 (Pubitemid 351281570)
21. Gullo D, Latina A, Frasca F, Le Moli R, Pellegriti G, Vigneri R 2011 Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients. PLoS One 6:e22552
22. Butler PW, Smith SM, Linderman JD, Brychta RJ, Alberobello AT, Dubaz OM, Luzon JA, Skarulis MC, Cochran CS, Wesley RA, Pucino F, Celi FS 2010 The Thr92Ala 5′ type 2 deiodinase gene polymorphism is associated with a delayed triiodothyronine secretion in response to the thyrotropin-releasing hormone stimulation test: a pharmacogenomic study. Thyroid 20:1407-1412
23. Peeters RP, van den Beld AW, van Toor H, Uitterlinden AG, Janssen JA, Lamberts SW, Visser TJ 2005 A polymorphism in type I deiodinase is associated with circulating free insulin-like growth factor I levels and body composition in humans. J Clin Endocrinol Metab 90:256-263 (Pubitemid 40116666)
24. Canani LH, Capp C, Dora JM, Meyer EL, Wagner MS, Harney JW, Larsen PR, Gross JL, Bianco AC, Maia AL 2005 The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 90:3472-3478 (Pubitemid 41014316)
25. Escobar-Morreale HF, Botella-Carretero JI, Escobar del Rey F, Morreale de Escobar G 2005 Treatment of hypothyroidism with combinations of levothyroxine plus liothyronine. J Clin Endocrinol Metab 90:4946-4954 (Pubitemid 41159395)
26. Escobar-Morreale HF, del Rey FE, Obregón MJ, de Escobar GM 1996 Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of the thyroidectomized rat. Endocrinology 137:2490-2502 (Pubitemid 26155786)
27. Utiger RD 1994 Subclinical hyperthyroidism-just a low serum thyrotropin concentration, or something more? N Engl J Med 331: 1302-1303 (Pubitemid 24333196)
28. Hennessey JV, Evaul JE, Tseng YC, Burman KD, Wartofsky L 1986 L-Thyroxine dosage: a reevaluation of therapy with contemporary preparations. Ann Intern Med 105:11-15 (Pubitemid 16097914)
29. Samuels MH, Schuff KG, Carlson NE, Carello P, Janowsky JS 2007 Health status, psychological symptoms, mood, and cognition in Lthyroxine-treated hypothyroid subjects. Thyroid 17:249-258 (Pubitemid 46557374)
30. Dugbartey AT 1998 Neurocognitive aspects of hypothyroidism. Arch Intern Med 158:1413-1418 (Pubitemid 28317756)
31. Zhu DF, Wang ZX, Zhang DR, Pan ZL, He S, Hu XP, Chen XC, Zhou JN 2006 fMRI revealed neural substrate for reversible working memory dysfunction in subclinical hypothyroidism. Brain 129: 2923-2930 (Pubitemid 44684513)
32. Bauer M, Silverman DH, Schlagenhauf F, London ED, Geist CL, van Herle K, Rasgon N, Martinez D, Miller K, van Herle A, Berman SM, Phelps ME, Whybrow PC 2009 Brain glucose metabolism in hypothyroidism: a positron emission tomography study before and after thyroid hormone replacement therapy. J Clin Endocrinol Metab 94:2922-2929
33. Saravanan P, Chau WF, Roberts N, Vedhara K, Greenwood R, Dayan CM 2002 Psychological well-being in patients on 'adequate'doses of L-thyroxine: results of a large, controlled community-based questionnaire study. Clin Endocrinol (Oxf) 57:577-585 (Pubitemid 35316973)
34. Carr D, McLeod DT, Parry G, Thornes HM 1988 Fine adjustment of thyroxine replacement dosage: comparison of the thyrotrophin releasing hormone test using a sensitive thyrotrophin assay with measurement of free thyroid hormones and clinical assessment. Clin Endocrinol (Oxf) 28:325-333 (Pubitemid 18079402)
35. Walsh JP, Ward LC, Burke V, Bhagat CI, Shiels L, Henley D, Gillett MJ, Gilbert R, Tanner M, Stuckey BG 2006 Small changes in thyroxine dosage do not produce measurable changes in hypothyroid symptoms, well-being, or quality of life: results of a double-blind, randomized clinical trial. J Clin Endocrinol Metab 91:2624-2630 (Pubitemid 44024628)
36. Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange Jr AJ 1999 Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med 340:424-429 (Pubitemid 29084773)
37. Sawka AM, Gerstein HC, Marriott MJ, MacQueen GM, Joffe RT 2003 Does a combination regimen of thyroxine (T4) and 3,5,3′-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial. J Clin Endocrinol Metab 88:4551-4555 (Pubitemid 37357491)
38. Appelhof BC, Fliers E, Wekking EM, Schene AH, Huyser J, Tijssen JG, Endert E, van Weert HC, Wiersinga WM 2005 Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial. J Clin Endocrinol Metab 90:2666-2674 (Pubitemid 40686307)
39. Walsh JP, Shiels L, Lim EM, Bhagat CI, Ward LC, Stuckey BG, Dhaliwal SS, Chew GT, Bhagat MC, Cussons AJ 2003 Combined thyroxine/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism. J Clin Endocrinol Metab 88:4543-4550 (Pubitemid 37357490)
40. Clyde PW, Harari AE, Getka EJ, Shakir KM 2003 Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial. JAMA 290: 2952-2958 (Pubitemid 37505527)
41. Saravanan P, Simmons DJ, Greenwood R, Peters TJ, Dayan CM 2005 Partial substitution of thyroxine (T4) with tri-iodothyronine in patients on T4 replacement therapy: results of a large community-based randomized controlled trial. J Clin Endocrinol Metab 90: 805-812 (Pubitemid 40279201)
42. Fadeyev VV, Morgunova TB, Sytch JP, Melnichenko GA 2005 TSH and thyroid hormones concentrations in patients with hypothyroidism receiving replacement therapy with L-thyroxine alone or in combination with L-triiodothyronine. Hormones 4:101-107
43. Regalbuto C, Maiorana R, Alagona C, Paola RD, Cianci M, Alagona G, Sapienza S, Squatrito S, Pezzino V 2007 Effects of either LT4 monotherapy or LT4/LT3 combined therapy in patients totally thyroidectomized for thyroid cancer. Thyroid 17:323-331 (Pubitemid 46776136)
44. Smith RN, Taylor SA, Massey JC 1970 Controlled clinical trial of combined triiodothyronine and thyroxine in the treatment of hypothyroidism. BMJ 4:145-148
45. Rodriguez T, Lavis VR, Meininger JC, Kapadia AS, Stafford LF 2005 Substitution of liothyronine at a 1:5 ratio for a portion of levothyroxine: effect on fatigue, symptoms of depression, and working memory versus treatment with levothyroxine alone. Endocr Pract 11:223-233
46. Escobar-Morreale HF, Botella-Carretero JI, Gómez-Bueno M, Galán JM, Barrios V, Sancho J 2005 Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone. Ann Intern Med 142:412-424
47. Siegmund W, Spieker K, Weike AI, Giessmann T, Modess C, Dabers T, Kirsch G, Sänger E, Engel G, Hamm AO, Nauck M, Meng W 2004 Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14:1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism. Clin Endocrinol (Oxf) 60:750-757 (Pubitemid 38788084)
48. Nygaard B, Jensen EW, Kvetny J, Jarløv A, Faber J 2009 Effect of combination therapy with thyroxine (T4) and 3,5,3′-triiodothyronine versus T4 monotherapy in patients with hypothyroidism, a double-blind, randomised cross-over study. Eur J Endocrinol 161: 895-902
49. Cappola AR, Ladenson PW 2003 Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab 88:2438-2444 (Pubitemid 36724408)
50. Rodondi N, Bauer DC, Cappola AR, Cornuz J, Robbins J, Fried LP, Ladenson PW, Vittinghoff E, Gottdiener JS, Newman AB 2008 Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure. The Cardiovascular Health Study. J Am Coll Cardiol 52: 1152-1159
51. Rodondi N, den Elzen WP, Bauer DC, Cappola AR, Razvi S, Walsh JP, Asvold BO, Iervasi G, Imaizumi M, Collet TH, Bremner A, Maisonneuve P, Sgarbi JA, Khaw KT, Vanderpump MP, Newman AB, Cornuz J, Franklyn JA, Westendorp RG, Vittinghoff E, Gussekloo J 2010 Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 304:1365-1374
52. Lomenick JP, El-Sayyid M, Smith WJ 2008 Effect of levo-thyroxine treatment on weight and body mass index in children with acquired hypothyroidism. J Pediatr 152:96-100 (Pubitemid 350265927)
53. Hoogwerf BJ, Nuttall FQ 1984 Long-term weight regulation in treated hyperthyroid and hypothyroid subjects. Am J Med 76:963-970 (Pubitemid 14120399)
54. Franklyn JA, Daykin J, Betteridge J, Hughes EA, Holder R, Jones SR, Sheppard MC 1993 Thyroxine replacement therapy and circulating lipid concentrations. Clin Endocrinol (Oxf) 38:453-459 (Pubitemid 23153405)
55. Clausen P, Mersebach H, Nielsen B, Feldt-Rasmussen B, Feldt-Rasmussen U 2009 Hypothyroidism is associated with signs of endothelial dysfunction despite 1-year replacement therapy with levothyroxine. Clin Endocrinol (Oxf) 70:932-937
56. Flynn RW, Macdonald TM, Jung RT, Morris AD, Leese GP 2006 Mortality and vascular outcomes in patients treated for thyroid dysfunction. J Clin Endocrinol Metab 91:2159-2164 (Pubitemid 43854999)
57. al-Adsani H, Hoffer LJ, Silva JE 1997 Resting energy expenditure is sensitive to small dose changes in patients on chronic thyroid hormone replacement. J Clin Endocrinol Metab 82:1118-1125 (Pubitemid 27166652)
58. Bunevicius R, Jakubonien N, Jurkevicius R, Cernicat J, Lasas L, Prange Jr AJ 2002 Thyroxine vs thyroxine plus triiodothyronine in treatment of hypothyroidism after thyroidectomy for Graves' disease. Endocrine 18:129-133
59. Alevizaki M, Mantzou E, Cimponeriu AT, Alevizaki CC, Koutras DA 2005 TSH may not be a good marker for adequate thyroid hormone replacement therapy. Wien Klin Wochenschr 117:636-640
60. Waung JA, Bassett JH, Williams GR 2012 Thyroid hormone metabolism in skeletal development and adult bone maintenance. Trends Endocrinol Metab 23:155-162
61. Bunevicius R, Prange AJ 2000 Mental improvement after replacement therapy with thyroxine plus triiodothyronine: relationship to cause of hypothyroidism. Int J Neuropsychopharmacol 3:167-174 (Pubitemid 30429360)
62. Vestergaard P, Weeke J, Hoeck HC, Nielsen HK, Rungby J, Rejnmark L, Laurberg P, Mosekilde L 2000 Fractures in patients with primary idiopathic hypothyroidism. Thyroid 10:335-340 (Pubitemid 30256863)
63. Turner MR, Camacho X, Fischer HD, Austin PC, Anderson GM, Rochon PA, Lipscombe LL 2011 Levothyroxine dose and risk of fractures in older adults: nested case-control study. BMJ 342:d2238
64. Wartofsky L 2004 Combined levotriiodothyronine and levothyroxine therapy for hypothyroidism: are we a step closer to the magic formula? Thyroid 14:247-248 (Pubitemid 38569273)
65. Wiersinga WM 2009 Do we need still more trials on T4 and T3 combination therapy in hypothyroidism? Eur J Endocrinol 161: 955-959
66. Kim BW, Bianco AC 2009 For some, L-thyroxine replacement might not be enough: a genetic rationale. J Clin Endocrinol Metab 94:1521-1523
67. Panicker V, Saravanan P, Vaidya B, Evans J, Hattersley AT, Frayling TM, Dayan CM 2009 Common variation in the DIO2 gene predicts baseline psychological well-being and response to combination thyroxine plus triiodothyronine therapy in hypothyroid patients. J Clin Endocrinol Metab 94:1623-1629
68. Pilhatsch M, Marxen M, Winter C, Smolka MN, Bauer M 2011 Hypothyroidism and mood disorders: integrating novel insights from brain imaging techniques. Thyroid Res 4(Suppl 1):S3
69. Wekking EM, Appelhof BC, Fliers E, Schene AH, Huyser J, Tijssen JG, Wiersinga WM 2005 Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidism. Eur J Endocrinol 153:747-753 (Pubitemid 43020224)
70. Verburg FA, Smit JW, Grelle I, Visser TJ, Peeters RP, Reiners C 2012 Changes within the thyroid axis after long-term TSH-suppressive levothyroxine therapy. Clin Endocrinol (Oxf) 76:577-581
71. Hoftijzer HC, Heemstra KA, Visser TJ, le Cessie S, Peeters RP, Corssmit EP, Smit JW 2011 The type 2 deiodinase ORFa-Gly3Asp polymorphism (rs12885300) influences the set point of the hypothalamus-pituitary-thyroid axis in patients treated for differentiated thyroid carcinoma. J Clin Endocrinol Metab 96:E1527-E1533
72. Fish LH, Schwartz HL, Cavanaugh J, Steffes MW, Bantle JP, Oppenheimer JH 1987 Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans. N Engl J Med 316:764-770 (Pubitemid 17046084)
73. Hennemann G, Docter R, Visser TJ, Postema PT, Krenning EP 2004 Thyroxine plus low-dose, slow-release triiodothyronine replacement in hypothyroidism: proof of principle. Thyroid 14:271-275 (Pubitemid 38569276)
74. Biondi B, Cooper DS 2010 Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer. Thyroid 20:135-146
75. Gammage MD, Parle JV, Holder RL, Roberts LM, Hobbs FD, Wilson S, Sheppard MC, Franklyn JA 2007 Association between serum free thyroxine concentration and atrial fibrillation. Arch Intern Med 167:928-934 (Pubitemid 46762755)
76. Gold MS, Pottash AL, Extein I 1981 Hypothyroidism and depression - evidence from complete thyroid-function evaluation. JAMA 245:1919-1922 (Pubitemid 11099195)
77. Pop VJ, Maartens LH, Leusink G, van Son MJ, Knottnerus AA, Ward AM, Metcalfe R, Weetman AP 1998 Are autoimmune thyroid dysfunction and depression related? J Clin Endocrinol Metab 83: 3194-3197 (Pubitemid 28500956)
78. Carta MG, Loviselli A, Hardoy MC, Massa S, Cadeddu M, Sardu C, Carpiniello B, Dell'Osso L, Mariotti S 2004 The link between thyroid autoimmunity (antithyroid peroxidase autoantibodies) with anxiety and mood disorders in the community: a field of interest for public health in the future. BMC Psychiatry 4:25
79. Engum A, Bjøro T, Mykletun A, Dahl AA 2005 Thyroid autoimmunity, depression and anxiety; are there any connections? An epidemiological study of a large population. J Psychosom Res 59:263-268 (Pubitemid 41531377)
80. Rosenthal LJ, Goldner WS, O'Reardon JP 2011 T3 augmentation in major depressive disorder: safety considerations. Am J Psychiatry 168:1035-1040
81. Kirkegaard C, Faber J 1998 The role of thyroid hormones in depression. Eur J Endocrinol 138:1-9 (Pubitemid 28078802)
82. Aronson R, Offman HJ, Joffe RT, Naylor CD 1996 Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis. Arch Gen Psychiatry 53:842-848 (Pubitemid 26303624)
83. Altshuler LL, Bauer M, Frye MA, Gitlin MJ, Mintz J, Szuba MP, Leight KL, Whybrow PC 2001 Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature. Am J Psychiatry 158:1617-1622 (Pubitemid 32923653)
84. Cooper-Kazaz R, Apter JT, Cohen R, Karagichev L, Muhammed-Moussa S, Grupper D, Drori T, Newman ME, Sackeim HA, Glaser B, Lerer B 2007 Combined treatment with sertraline and liothyronine in major depression: a randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry 64:679-688 (Pubitemid 46878668)
85. Mentuccia D, Proietti-Pannunzi L, Tanner K, Bacci V, Pollin TI, Poehlman ET, Shuldiner AR, Celi FS 2002 Association between a novel variant of the human type 2 deiodinase gene Thr92Ala and insulin resistance: evidence of interaction with the Trp64Arg variant of the β-3-adrenergic receptor. Diabetes 51:880-883 (Pubitemid 34760206)
86. Gumieniak O, Perlstein TS, Williams JS, Hopkins PN, Brown NJ, Raby BA, Williams GH 2007 Ala92 type 2 deiodinase allele increases risk for the development of hypertension. Hypertension 49: 461-466
87. Appelhof BC, Peeters RP, Wiersinga WM, Visser TJ, Wekking EM, Huyser J, Schene AH, Tijssen JG, Hoogendijk WJ, Fliers E 2005 Polymorphisms in type 2 deiodinase are not associated with well-being, neurocognitive functioning, and preference for combined thyroxine/3,5,3′-triiodothyronine therapy. J Clin Endocrinol Metab 90:6296-6299 (Pubitemid 41606559)
88. Heemstra KA, Hoftijzer HC, van der Deure WM, Peeters RP, Fliers E, Appelhof BC, Wiersinga WM, Corssmit EP, Visser TJ, Smit JW 2009 Thr92Ala polymorphism in the type 2 deiodinase is not associated with T4 dose in athyroid patients or patients with Hashimoto thyroiditis. Clin Endocrinol (Oxf) 71:279-283
89. Torlontano M, Durante C, Torrente I, Crocetti U, Augello G, Ronga G, Montesano T, Travascio L, Verrienti A, Bruno R, Santini S, D'Arcangelo P, Dallapiccola B, Filetti S, Trischitta V 2008 Type 2 deiodinase polymorphism (threonine 92 alanine) predicts L-thyroxine dose to achieve target thyrotropin levels in thyroidectomized patients. J Clin Endocrinol Metab 93:910-913 (Pubitemid 351398572)
90. Grozinsky-Glasberg S, Fraser A, Nahshoni E, Weizman A, Leibovici L 2006 Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: meta-analysis of randomized controlled trials. J Clin Endocrinol Metab 91:2592-2599 (Pubitemid 44024623)
91. Ma C, Xie J, Huang X, Wang G, Wang Y, Wang X, Zuo S 2009 Thyroxine alone or thyroxine plus triiodothyronine replacement therapy for hypothyroidism. Nucl Med Commun 30:586-593
92. Joffe RT, Brimacombe M, Levitt AJ, Stagnaro-Green A 2007 Treatment of clinical hypothyroidism with thyroxine and triiodothyronine: a literature review and metaanalysis. Psychosomatics 48:379-384 (Pubitemid 47330290)
93. Duntas LH, Biondi B 2007 Short-term hypothyroidism after levothyroxine withdrawal in patients with differentiated thyroid cancer: clinical and quality of life consequences. Eur J Endocrinol 156: 13-19 (Pubitemid 46553899)
94. Celi FS, Zemskova M, Linderman JD, Smith S, Drinkard B, Sachdev V, Skarulis MC, Kozlosky M, Csako G, Costello R, Pucino F 2011 Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine. J Clin Endocrinol Metab 96:3466-3474
95. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC 2000 The Colorado Thyroid Disease Prevalence Study. Arch Intern Med 160: 526-534 (Pubitemid 30112276)